Meta AnalysisID 7331
苯甲酸钠用于阿尔茨海默病患者
CRD42023407830
Is sodium benzoate beneficial for the treatment of patients with Alzheimer's disease compared to placebo?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7331
- Evidence Id
- 15889
- Core Evidence Id
- 15889
- Source Meta Analysis Id
- 7319
- Herb2 Meta Analysis Id
- HBMA007319
- Crd Id
- CRD42023407830
- Title
- Sodium Benzoate for Patients with Alzheimer’s disease
- Review Question
- Is sodium benzoate beneficial for the treatment of patients with Alzheimer's disease compared to placebo?
- Study Type Included
- clinical trials
- Condition Being Studied
- Alzheimer's disease (All stages)
- Participant
- Patients with early , mid-stage, or advanced Alzheimer's disease
- Animal
- Human Disease Modelled
- Intervention
- sodium Benzoate (All doses)
- Comparator Control
- Placebo
- Main Outcome
- Change from baseline in Alzheimer's disease assessment scale-cognitive subscale
- Outcome Measure
- Additional Outcome
- Verbal learning and memory , Category Fluency, working memory (Wechsler Memory Scale, Spatial Span, Digit Span) , Clinician's Interview-Based Impression of Change plus Caregiver Input
- Study Method
- Intervention, Systematic review
- Keyword
- Alzheimer Disease; Benzoic Acid; Humans; Patients; Sodium Benzoate
- Contact
- Ahmed Ali [email protected]
- Organisational Affiliation
- Medical Research Group of Egypt, Negida Academy, Arlington, MA
- Funding Source
- None Grant number(s) State the funder, grant or award number and the date of award Not applicable
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Egypt, Russian Federation
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-03-13
- Registration Date
- 2023-03-24
- Anticipated Start Date
- 2023-03-13
- Anticipated Completion Date
- 2023-05-08
- Title Cn
- 苯甲酸钠用于阿尔茨海默病患者
- Title En
- Sodium Benzoate for Patients with Alzheimer’s disease
- Bilingual Status
- complete